INTERVACC
Intervacc is a biotechnology company which develop new vaccines to meet the increasing need for effective vaccines in animal health care.
INTERVACC
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2001-01-01
Address:
Hägersten, Stockholms Lan, Sweden
Country:
Sweden
Website Url:
http://www.intervacc.com
Total Employee:
11+
Status:
Active
Contact:
08-120 10 600
Email Addresses:
[email protected]
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS
Similar Organizations
Antagene
Antagene is a biotechnology company which develops and sells DNA tests witin the framework of animal health, veterinary diagnosis.
Biosearch Life
e is a biotechnology company that develops and manufactures products through the innovation of natural ingredients.
Cutech
Cutech is a biotechnology company, engages in the design of informative skin and hair follicle screening models.
LiteVax
LiteVax is a biotechnology company that creates vaccines against infectious and non-infectious diseases.
Oroxcell
Oroxcell is a leading company in developing and creating alternative methods to animal use.
Progentix Orthobiology
Progentix Orthobiology is developing synthetic bone substitutes designed to accelerate bone healing through a novel microstructure.
Current Employees Featured
Official Site Inspections
http://www.intervacc.com
- Host name: premium14.oderland.com
- IP address: 91.201.60.72
- Location: Sweden
- Latitude: 59.3247
- Longitude: 18.056
- Timezone: Europe/Stockholm
More informations about "Intervacc"
Intervacc - Crunchbase Company Profile & Funding
Intervacc develops vaccines based on recombinant proteins for use in animal health care. They focus on diagnostics in the animal health market and provide bacteriological and mycological analyzes.See details»
A new generation of vaccines within animal health - Intervacc
Dec 6, 2024 Together with our two subsidiaries Nordvacc Läkemedel and the Mybac-Vettech Laboratory, we strive to strengthen animal health and welfare. Here you can find more about …See details»
Intervacc Company Profile - Office Locations, Competitors, …
Oct 29, 2024 Intervacc kr8.02 m in annual revenue in FY 2023. See insights on Intervacc including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
Intervacc - Products, Competitors, Financials, Employees, …
Strangvac is back in stock on all launched markets. Dec 6, 2024. Intervacc Fri, Dec 06, 2024 12:45 CET Stockholm, December 6, 2024 – Intervacc AB (publ) announces that Strangvac, a …See details»
About us - Intervacc
Intervacc develop novel veterinary vaccines and the pipeline is based on new technology using recombinant proteins rather than attenuated live strains found in conventional vaccines. This …See details»
Intervacc - Company Profile - Tracxn
Aug 17, 2021 Intervacc is a biotechnology company developing vaccines based on recombinant proteins. As of May 2017, the company is working on three projects which are: (a) Strangvac a …See details»
Intervacc - Funding, Financials, Valuation & Investors - Crunchbase
Intervacc is a biotechnology company that develops vaccines based on recombinant proteins for animal health.See details»
Intervacc AB Overview | SignalHire Company Profile
Intervacc AB is a private company that has been in the industry for 23 years. The company currently specializes in the Pharmaceuticals area. The position of the CEO is occupied by …See details»
Intervacc AB: Governance, Directors and Executives & Committees ...
Dec 12, 2018 Intervacc AB is a Sweden-based biotechnology company. It develops vaccines based on recombinant proteins for animal health care. The Companyâ s candidate vaccine …See details»
Intervacc Company Profile: Stock Performance & Earnings
Information on stock, financials, earnings, subsidiaries, investors, and executives for Intervacc. Use the PitchBook Platform to explore the full profile.See details»
Company Intervacc AB - MarketScreener.com
Dec 31, 2000 Intervacc AB is a Sweden-based biotechnology company. It develops vaccines based on recombinant proteins for animal health care. The Companyâ s candidate vaccine …See details»
Intervacc publishes the 2022 Annual Report - Intervacc
Apr 6, 2023 For more information please contact: Andreas Andersson, CEO Phone: +46-8-120 10 601, cell +46-73-335 99 70 E-mail: [email protected]See details»
Intervacc Investor Relations Material - Quartr
Access Intervacc (IVACC) Investor Relations material, such as Live Earnings Calls, Transcripts, Slides, Reports, and Estimates using QuartrSee details»
Intervacc AB, IVACC:STO profile - FT.com - Financial Times
4 days ago Intervacc AB is a Sweden-based biotechnology company. It develops vaccines based on recombinant proteins for animal health care. The Company’s candidate vaccine …See details»
Intervax Ltd - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Intervax Ltd of Markham, ON. Get the latest business insights from Dun & Bradstreet.See details»
Governance Intervacc AB Nasdaq Stockholm - MarketScreener.com
Dec 12, 2018 Intervacc AB is a Sweden-based biotechnology company. It develops vaccines based on recombinant proteins for animal health care. The Companyâ s candidate vaccine …See details»
Intervac - International Vaccine Centre - Architecture49
The University of Saskatchewan partnered with the Vaccine and Infectious Disease Organization to construct one of the largest facilities of its kind in the world. It provides a degree of research …See details»
Intervac Home Exchange - The original home exchange service
Intervac isn't just an organization, it is a way of life! Our founders discovered and pioneered travelling through home exchanges. Since 1953 we have been leading the way facilitating …See details»
phuket international accounting auditing and business consulting …
Welcome to A. Accounting & Tax Business and Phuket International Accounting and Business Consulting Firm. We are a full-service accounting, tax preparation and business consulting …See details»